Loading...
XJPX4880
Market cap102mUSD
Jan 14, Last price  
814.00JPY
1D
-1.93%
1Q
-31.94%
IPO
4.36%
Name

CellSource Co Ltd

Chart & Performance

D1W1MN
XJPX:4880 chart
P/E
17.47
P/S
3.57
EPS
46.60
Div Yield, %
0.00%
Shrs. gr., 5y
8.25%
Rev. gr., 5y
30.04%
Revenues
4.51b
+5.54%
519,062,0001,212,730,0001,611,587,0001,855,475,0002,922,232,0004,273,829,0004,510,544,000
Net income
923m
-9.30%
111,400,000193,400,000199,606,000274,082,000651,396,0001,017,842,000923,142,000
CFO
847m
-0.11%
109,942,000213,967,000195,287,000330,225,000898,194,000847,603,000846,691,000
Dividend
Oct 30, 20245 JPY/sh

Profile

CellSource Co., Ltd. engages in the regenerative medicine-related and consumer businesses. It also offers Signalift, an anti-aging product. The company was incorporated in 2015 and is headquartered in Tokyo, Japan.
IPO date
Oct 28, 2019
Employees
109
Domiciled in
JP
Incorporated in
JP

Valuation

Title
JPY in thousands, except ratios and share amounts
FYFYFYFYFYFYFY
2023‑102022‑102021‑102020‑102019‑102018‑102017‑10
Income
Revenues
4,510,544
5.54%
4,273,829
46.25%
Cost of revenue
1,956,203
1,722,571
Unusual Expense (Income)
NOPBT
2,554,341
2,551,258
NOPBT Margin
56.63%
59.69%
Operating Taxes
316,540
565,796
Tax Rate
12.39%
22.18%
NOPAT
2,237,801
1,985,462
Net income
923,142
-9.30%
1,017,842
56.26%
Dividends
Dividend yield
Proceeds from repurchase of equity
1,461,669
15,266
BB yield
Debt
Debt current
20,251
Long-term debt
174,833
Deferred revenue
Other long-term liabilities
148,709
(1,569)
Net debt
(4,737,978)
(3,295,009)
Cash flow
Cash from operating activities
846,691
847,603
CAPEX
(349,000)
(99,167)
Cash from investing activities
(624,080)
(169,388)
Cash from financing activities
1,449,123
14,421
FCF
1,153,008
1,771,748
Balance
Cash
4,781,022
3,123,580
Long term investments
152,040
171,429
Excess cash
4,707,535
3,081,318
Stockholders' equity
4,802,716
3,787,225
Invested Capital
1,740,296
180,566
ROIC
233.00%
4,017.44%
ROCE
39.62%
78.18%
EV
Common stock shares outstanding
19,260
19,213
Price
Market cap
EV
EBITDA
2,620,717
2,596,680
EV/EBITDA
Interest
379
11
Interest/NOPBT
0.01%
0.00%